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Abstract
Background: Computer-coded verbal autopsy (CCVA) methods to assign causes of death (CODs) for medically
unattended deaths have been proposed as an alternative to physician-certified verbal autopsy (PCVA). We
conducted a systematic review of 19 published comparison studies (from 684 evaluated), most of which used
hospital-based deaths as the reference standard. We assessed the performance of PCVA and five CCVA methods:
Random Forest, Tariff, InterVA, King-Lu, and Simplified Symptom Pattern.
Methods: The reviewed studies assessed methods’ performance through various metrics: sensitivity, specificity, and
chance-corrected concordance for coding individual deaths, and cause-specific mortality fraction (CSMF) error and
CSMF accuracy at the population level. These results were summarized into means, medians, and ranges.
Results: The 19 studies ranged from 200 to 50,000 deaths per study (total over 116,000 deaths). Sensitivity of PCVA
versus hospital-assigned COD varied widely by cause, but showed consistently high specificity. PCVA and CCVA
methods had an overall chance-corrected concordance of about 50% or lower, across all ages and CODs. At the
population level, the relative CSMF error between PCVA and hospital-based deaths indicated good performance for
most CODs. Random Forest had the best CSMF accuracy performance, followed closely by PCVA and the other
CCVA methods, but with lower values for InterVA-3.
Conclusions: There is no single best-performing coding method for verbal autopsies across various studies and
metrics. There is little current justification for CCVA to replace PCVA, particularly as physician diagnosis remains the
worldwide standard for clinical diagnosis on live patients. Further assessments and large accessible datasets on which
to train and test combinations of methods are required, particularly for rural deaths without medical attention.
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Background
Most of the 48 million deaths that occurred in 2010 in
low- and middle-income countries (LMICs) occurred
without medical attention, in homes in rural areas
[1-3]. Verbal autopsy (VA) has been increasingly used
in LMICs to define causes of death (CODs). VA entails
an interview with a relative or close associate of the
deceased, using a questionnaire to elicit information
on the signs, symptoms and chronological sequence of
events during the final illness leading to death. VA
questionnaires vary, but generally comprise a mix of
closed questions and open or semi-structured narra-
tives. COD surveys have mostly informed specific re-
search needs in small populations, and have largely
focused on child or maternal deaths [4]. Increasingly
there is interest in the use of VA for large-scale na-
tionally representative COD surveys, such as the on-
going Indian Million Death Study (MDS) [5,6] and
others in Africa [7].
Methods to assign COD in VAs can be categorized as
physician-certified verbal autopsy (PCVA) or computer-
coded verbal autopsy (CCVA) (Figure 1). PCVA typically
involves at least two physicians examining each record,
with adjudication done by a consensus review or by a
third physician [8,9]. In recent years, there has been
interest in using CCVA to improve inter-observer agree-
ment, consistency and comparability, and to make the
coding of VAs faster and cheaper. We conducted a sys-
tematic review of studies assessing the performance of
CCVA and PCVA methods. Most studies used hospital-
based diagnosis as the reference comparison. Thus, we
also discuss the relevance of the findings to rural or
medically unattended deaths, populations among whom
VA studies are needed most urgently.
Methods
We conducted a systematic review of VA performance
studies, adhering broadly to PRISMA guidelines [10], and
compared five CCVA methods to PCVA: two data-driven
algorithms, Random Forest (RF) and Tariff; InterVA, an
expert-based probabilistic method; and two data-driven
probabilistic methods, King-Lu (KL) and Simplified
Symptom Pattern (SSP) (Figure 1) [11-16]. Additional
file 1 offers background information on these methods.
Various versions of InterVA models have been available
in the public domain since 2003; most of the studies
here used InterVA-3 rather than the current InterVA-4
model [15,17].
Two of the authors (JL, ND) independently searched
three online databases (PubMed, Popline, and LILACS)
for relevant studies; disagreements were handled by JL,
and a senior author (PJ) resolved any differences. A search
of the EMBASE database yielded no additional relevant
studies. Key terms employed in the electronic searches
were verbal autopsy, cause of death, validity, validation,
performance, accuracy, and assessment. The literature
search was concluded in June 2013.
The validity of VA is dependent on its many components
and there is a high degree of variability between studies
in terms of field procedures, questionnaires used, CODs
assessed, recall by respondents, and metrics of perform-
ance, among others. To ensure comparability and qual-
ity of studies, we included only studies that fitted
our eligibility criteria. Firstly, as the validity of VA depends
heavily on the questions used, only studies using the
most common and validated questionnaires were eli-
gible. These included an adaptation or sub-version of the
following VA questionnaires: World Health Organization
VA tools; INDEPTH; London School of Hygiene and
Figure 1 Classification of verbal autopsy interpretation methods.
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Tropical Medicine VA; Sample Vital Registration with
Verbal Autopsy; Routine, Reliable, Representative and
Resampled Household Investigation of Mortality with
Medical Evaluation (MDS); or questionnaires used in
the mortality surveillance systems of Tanzania and China
[5,18-25]. Guidance for these questionnaires also came
from a World Health Organization review meeting on
formulation of standard guidelines for its VA tool [26].
Secondly, PCVA coding must have been specifically
carried out by physicians and not by other types of
health professionals. Lastly, the study had to include at least
100 deaths for studies examining a single COD, and at least
1,000 total deaths for studies assessing various CODs.
The most important underlying measure of quality in
each study was the accuracy of diagnosis of the reference
standard, though this could not be addressed through
any additional criteria in this review. The search imposed
no restriction on the period of publication or language
used, and resulted in the selection of 19 studies from a
total of 684 screened articles. The systematic review
process is illustrated in Figure 2.
Two of the authors independently extracted the rele-
vant data from the selected studies. Various metrics are
used to assess the performance of VA methods. We se-
lected the most commonly reported metrics a priori so
as to increase comparability across the studies: sensitiv-
ity, specificity, and the cause-specific mortality fraction
(CSMF) error (the relative difference between the VA
and the reference standard CSMFs). The reference diag-
nosis in most studies was medically-assigned COD from
hospital-based deaths (Additional file 2). While there is
no international consensus on benchmark values of val-
idity, a working rule of thumb is to seek a sensitivity and
specificity of at least 80% at the individual level, and a
minimum sensitivity of 50% and specificity of 90% at the
population level. Low individual agreement may still pro-
duce accurate CSMFs at the population level as long as
false positives and false negatives balance each other out.
Hence, sensitivity thresholds are set lower than those for
specificity [26,27]. CSMFs were determined as the propor-
tion of all deaths that were attributable to a specific COD.
In studies where CSMF error was not reported, we calcu-
lated the relative difference between CSMFs from VA and
the reference standard, for selected CODs. While there is
also no agreed benchmark value for CSMF error, we
considered a relative difference of at least 10% between
CSMFs to represent significant disagreement.
The RF, Tariff, and SSP methods have only been
tested by the Institute of Health Metrics and Evaluation
(IHME) [21], and at the time of writing of this manu-
script, the datasets and methods for these hospital-based
comparisons were not in the public domain. From these
studies, we report the chance-corrected concordance
as a measure of individual performance, and CSMF accur-
acy as a measure of population-level performance. IHME
assessed the performance of VA methods with the inclu-
sion and exclusion of free text from the narrative and
household recall of healthcare experience. We chose to
only use the results for which performance was assessed
with the inclusion of all constituent parts of a VA ques-
tionnaire, as this is the form in which VA is administered
conventionally. InterVA-3 was the only method for which
IHME did not report performance for specific causes
with the inclusion of free text and household recall of
healthcare experience. To ensure a fair comparison
across the methods, we did not include the findings for
InterVA-3 for chance-corrected concordance or CSMF
accuracy by cause. Estimates of performance for adults,
children, neonates, and all ages combined from the
IHME group of studies were reported, while only
Figure 2 Systematic review process of studies assessing the performance of physician-certified verbal autopsy and computer-coded
verbal autopsy methods. Search terms used: verbal autopsy, cause of death, validity, validation, performance, accuracy, assessment.
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CODs for all ages combined were available in the re-
mainder of studies. Given the large amount of hetero-
geneity in the studies, including variation in methods
of data collection, forms used, age groups studied,
and single versus double coding by physicians, we did
not attempt formal meta-analytic summary measures
such as quantification of measures of heterogeneity. Rather,
simple means or medians, and ranges were calculated
across the various comparison studies.
Results
The review identified 19 eligible studies conducted be-
tween 1992 and 2012 assessing the performance of VA
methods [11-16,28-40]. Additional file 2 summarizes
the main characteristics of the included studies. The size
of the study samples ranged from 200 to 50,000 deaths,
for a total of 116,679 deaths. Fifteen out of nineteen
studies used hospital-assigned COD from medical
records as the reference standard, while the remaining
four assessed InterVA-3 using PCVA as a reference standard.
Fifteen studies assessed performance across a range of
CODs, and four assessed a single COD. Eleven studies
assessed performance across all ages, while seven
assessed performance specifically in adolescents and
adults (defined as age 12 years and above), and one in
children under 5 years of age. We included eight studies
evaluating the performance of PCVA, seven studies
evaluating InterVA, and one study for each of the KL,
RF, Tariff and SSP methods.
Individual-level cause of death assignment
Table 1 shows the means and ranges of sensitivity and
specificity reported for PCVA for 21 major CODs. Sensitiv-
ity varied considerably, with wide ranges of estimates across
specific CODs (0% to 98%). On average, PCVA was reason-
ably accurate when compared to hospital-based diagnosis
for HIV/AIDS, site-specific cancers, cirrhosis of the liver,
stroke, chronic respiratory diseases, maternal deaths, road
traffic accidents, and other injuries. PCVA achieved
the highest levels of accuracy in certifying road traffic
accidents and digestive cancers with median sensitivity
values of 97% (97% to 98%) and 84% (80% to 89%),
respectively. By contrast, PCVA was relatively poor at
confirming hospital-based diagnosis of infections, other
digestive diseases, nutritional conditions, heart diseases,
renal and other endocrine diseases, and neonatal condi-
tions. PCVA had the poorest performance for renal and
other endocrine diseases, with a mean sensitivity of 32%
(13% to 54%). PCVA yielded good levels of specificity of at
least 90% for the majority of CODs, with the exception of
malaria, with a mean of 89% (0% to 100%). In one hospital-
based study, InterVA-3 appears to more accurately ascer-
tain HIV/AIDS than PCVA, with a mean sensitivity of 87%,
but with a lower specificity of 77% (76% to 78%; data not
shown). Another study found InterVA-3 to have a sensitiv-
ity of 82% and specificity of 78% in the certification of
tuberculosis in relation to PCVA [39,40].
Table 2 presents the median chance-corrected concord-
ance from the IHME group of hospital-based studies
for five VA methods, by age. All the VA methods had
an overall chance-corrected concordance lower than
50% for combined age groups. RF reported the highest
chance-corrected concordance (45%), followed closely
by PCVA (42%) and SSP (40%). Within age groups, RF
and SSP achieved moderate levels of performance in
children (51% and 52%, respectively). Median values of
chance-corrected concordance were calculated for se-
lected CODs (Additional file 3), with PCVA, Tariff, RF
and SSP trading best performance by individual CODs;
all methods had a chance-corrected concordance above
50% for HIV/AIDS (54% to 64%), maternal deaths
(64% to 89%), stroke (50% to 63%), road traffic accidents
(66% to 85%) and other injuries (57% to 61%). The
highest accuracy was achieved for road traffic acci-
dents (85%, by RF and PCVA) and maternal deaths
(89% and 75%, by SSP and RF). Largely, all the methods
performed poorly in certifying various infections, par-
ticularly pneumonia (17% to 27%) and other infections
(5% to 25%). Among noncommunicable causes, simi-
larly low performance was seen for vascular diseases
(9% to 30%), other digestive diseases (21% to 27%),
chronic respiratory diseases (43% to 49%), renal and
other endocrine diseases (12% to 33%), and neonatal
conditions (6% to 48%).
Population-level cause of death assignment
The CSMF error between PCVA and hospital-based deaths,
and between InterVA-3 and PCVA, are shown in Figure 3.
The CSMFs for nearly all causes estimated by PCVA did
not differ significantly from the reference standard. The
notable exception was other cardiovascular diseases, with
a mean difference of 7%, ranging between 4% and 10%.
InterVA-3 had close agreement in CSMF estimation com-
pared with PCVA for most of the selected CODs. However,
InterVA-3 had considerably higher CSMF relative errors
for tuberculosis (10%), birth asphyxia and birth trauma
(24%), and neonatal infections (14%).
The median CSMF accuracy from IHME hospital-
based studies for adults, children, neonates and all ages
combined, for five VA methods, is shown in Table 3. At
all ages combined, RF had the highest median CSMF
accuracy (0.77), followed by SSP (0.74), tariff (0.71), KL
(0.70), PCVA (0.68), and InterVA-3 (0.52). Within age
groups, performance between the methods followed
similar trends as above, though KL achieved the best
performance (0.8) for neonates. However, the results
from the IHME studies were based on data-driven
models that were built from the same dataset that was
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used to evaluate their performance [42]. Consequently,
the results for RF, SSP and Tariff represented measures
of internal validity, alongside the IHME studies of PCVA
and InterVA-3, which reported measures of external valid-
ity against the IHME dataset.
Discussion
Our systematic review finds that no single VA method
consistently outperformed the others across selected CODs,
for both individual- and population-level COD assignment.
One challenging aspect of comparing validation studies is
Table 2 Median chance-corrected concordance (%) by age, for all causes of death, for physician-certified verbal
autopsy, InterVA-3, Tariff, Random Forest and Simplified Symptom Pattern, among hospital-based deaths
IHME sub-studies
Physician-certified
verbal autopsy
InterVA-3 Tariff Random forest Simplified
symptom pattern
Adults 45 25 45 48 46
Children 48 25 39 51 52
Neonates 33 7 24 35 33
All ages 42 19 36 45 43
The IHME studies provide an uncertainty limit, but these do not seem to reflect the true underlying source of error in the estimates, and to avoid false precision,
we do not show these [41]. IHME: Institute for Health Metrics and Evaluation.
Table 1 Mean, ranges and number of reviewed studies for sensitivity and specificity estimates of physician-certified
verbal autopsy for selected causes of death, among hospital-based deaths
Sensitivity Specificity
Mean (%) Range Number of studies Mean (%) Range Number of studies
Infections and parasitic diseases and maternal deaths
Tuberculosis 39 18 to 62 3 97 93 to 99 2
HIV/AIDS 59a 0 to 61 3 90a 0 to 96 3
Diarrheal diseasesb 38a 0 to 75 2 96 94 to 99 2
Malariab 60a 0 to 67 2 89a 0 to 100 2
Pneumonia 42 18 to 75 4 93 84 to 99 3
Maternal deaths 63 - 1 100 - 1
Neonatal conditions
Prematurity or low birth weight 48 - 1 95 - 1
Birth asphyxia or birth trauma 43 - 1 90 - 1
Neonatal infections 31 11 to 50 2 100 99 to 100 2
Noncommunicable diseases
Nutritional conditions 33a 0 to 58 2 94 87 to 99 2
Digestive cancers 82a 56 to 96 3 100 99 to 100 2
Respiratory cancers 84 80 to 89 2 99 - 1
Other cancers 61a 27 to 95 5 99 98 to 99 2
Heart disease 39 16 to 64 3 98 98 to 99 2
Stroke 71 63 to 82 3 95 94 to 97 2
Chronic respiratory diseases 61 60 to 62 2 98 - 1
Cirrhosis of the liver 58 45 to 71 2 98 - 1
Other digestive diseases 36 21 to 52 2 99 - 1
Renal or endocrine diseases 32 13 to 54 3 99 99 to 99.4 2
Injuries
Road traffic accidents 97 97 to 98 2 100 - 1
Other injuries 57 35.3 to 74 3 100 99 to 100 2
aMedian was used instead of means due to outlier values in the ranges of estimates. However, the medians and means yielded similar results (that is, the pooled
studies gave PCVA a sensitivity mean of 80.1% and a median of 81.9% for ascertaining digestive cancers). bAlthough two studies were used to generate results for
these CODs, the studies provided results for several population sub-samples.
Leitao et al. BMC Medicine Page 5 of 92014, 12:22
http://www.biomedcentral.com/1741-7015/12/22
the variation in study design, particularly in regards to
reference standards and performance measures used.
In hospital-based comparison studies, each PCVA and
CCVA method had unique performance strengths for
various CODs. This is expected, as probabilistic methods
such as KL, InterVA and SSP assign a fixed probability
between each symptom indicator and each cause (for
example, the probability of loose bowel movements
being associated with death from diarrheal disease),
though in reality, for any given COD, symptomatology
might well differ between individuals. Moreover, in
comparison to PCVA, CCVA is weak at establishing the
chronology of events, which may have consequences for
diagnosis. For example, a history of cough or fever followed
by chest pain is more likely to indicate pneumonia than
a history of chest pain followed by a cough or fever, which
may signal cardiac conditions [43]. Moreover, physicians’
perceptions of local epidemiology can influence their
diagnosis in the absence of clear etiology, introducing
bias. This could be the case in the slight excess coding
of fever deaths such as malaria (and under-coding of
fevers of unknown origin) in areas of India where malaria
remains common [6]. Finally, the current clinical standard
for diagnosis in routine medical care worldwide remains a
Figure 3 Cause-specific mortality fraction relative error between physician-certified verbal autopsy and InterVA versus reference
standards, by cause of death. CSMF error is presented between PCVA and hospital-based deaths, and InterVA-3 and PCVA, from reviewed
studies. The bars of the graph are not comparable between PCVA and InterVA-3, as each used a different reference standard. CSMF, cause-specific
mortality fraction; PCVA, physician-certified verbal autopsy.
Table 3 Median cause-specific mortality fraction accuracy by age for all causes of death, among hospital-based deaths
IHME sub-studies
Physician-certified
verbal autopsy
InterVA-3 King and Lu Tariff Random forest Simplified
symptom pattern
Adults 0.68 0.55 0.67 0.75 0.77 0.71
Children 0.68 0.52 0.70 0.71 0.78 0.74
Neonates 0.73 0.41 0.80 0.68 0.73 0.75
All ages 0.68 0.52 0.70 0.71 0.77 0.74
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physician interview, and it is hard to imagine any pa-
tient accepting a computer-based diagnosis without
physician scrutiny.
One frequently stated advantage of CCVA methods over
PCVA is their repeatability and the temporal and spatial
comparability of CSMF estimation. This is likely true,
though a small, independent resample of the MDS showed
broad agreement in physician coding with the original
CODs assigned. Differences between physicians’ assignment
of COD exist at the individual level, but these differences
appear to have little impact on CSMF estimation, given that
misclassification tends to be bidirectional [44].
The development of data-driven algorithms requires
training and test datasets. Typically, a VA dataset containing
information about signs and symptoms coupled with
assigned CODs is used to train algorithms that then assign
CODs to a test dataset [45-48]. Data-derived methods, es-
pecially those trained on hospital deaths, may be limited in
three ways. First, development and testing on the same
dataset may be self-reinforcing, in that any bias in the VA
survey would be internalized during testing, and hence in-
flate the reported accuracy, as documented recently in
the IHME sub-studies [42]. Second, methods trained on
hospital-based causes may not have a sufficiently large sam-
ple from which to train on the CODs that are not common
in hospital settings such as malaria. Finally, training on
hospital-based deaths has uncertain external validity for
non-hospital deaths, because the symptomatology (as
well as the recall of the deceased’s relatives) may differ
between these populations. This review emphasizes
that each method has particular advantages for certain
CODs, and that the best performance may come from
using multiple methods, including the use of natural lan-
guage processing [49]. This places particular emphasis
on the need for expanded datasets for training and testing
to further compare CCVA methods with each other.
Currently, InterVA is the only CCVA method that deter-
mines COD from a universally applicable model, which is
not trained on any specific dataset. InterVA thus trades
maximization of performance in specific contexts with a
reasonable level of generalizability and comparability.
Two other operational aspects need to be considered
when designing VA studies. First, as both CCVA and
PCVA methods have been shown to generate reason-
ably robust COD estimates at the population level, the
most pressing need is to implement VA surveys much
more widely, particularly large-scale nationally representa-
tive surveys [1,3,50]. This would be a substantial advance-
ment over the dearth of COD data that exist in most
LMICs. Second, PCVA and CCVA have unique strengths
as coding methods; while PCVA is more dependent on
the quality of fieldwork and record-keeping than CCVA,
it is also more transparent, and the adjudication trail
from one physician to the next and final code is easily
followed. CCVA methods involve a ‘black box’ nature that
implies a leap of faith in trusting sometimes complex and
inaccessible assumptions. The MDS uses e-health records
to enable anonymous electronic coding by 300 physicians,
which makes coding faster than traditional paper-based
methods. The IHME group of studies found that, gener-
ally, the performance of the VA methods improved
with the inclusion of free text from the narrative and
information from health care use (data not shown),
which is similar to findings from the MDS [5]. This sug-
gests that a future strategy is to pair PCVA with CCVA,
to assist physicians’ decision making and further improve
and standardize physician coding. Currently, the Indian
MDS offers all coders a differential diagnosis based on the
initial physician disagreements of 130,000 deaths from
2001 to 2003 [44].
Metrics of performance were not consistent across the
studies. For InterVA, the main metric available was the
agreement between CSMF estimated by InterVA and
PCVA, which showed reasonably similar results for most
causes. When considering this agreement, its interpretation
as a measure of accuracy at the population level must
be made bearing in mind that PCVA is not 100% reliable
and does not yield high accuracy for all CODs. Although
sensitivity values for PCVA varied widely across causes
and settings, the specificity was generally high, rang-
ing from 89% to 100%. Specificity is more important
than sensitivity when comparing performance to the true
underlying CSMFs. Even a small loss of specificity leads to
underestimation of CSMF errors [27].
Finally, the most important limitation of the studies is
their use of mostly urban-based hospital reference stan-
dards. The accompanying paper by Aleksandrowicz et al.
demonstrates that, in India, there are marked differences in
the COD structure between urban or hospital deaths, and
rural or medically unattended deaths [44], even after tak-
ing into account differences in education or other social
status. Relatives who have had little interaction with doc-
tors and nurses during the events preceding death might
describe signs and symptoms very differently from those
whose relatives died in the hospital, and whose accounts
may be biased by what they are told by the doctors. Were
India’s COD estimates based solely on hospital data, the
CSMF proportions would differ substantially [41,51,52].
The most glaring example is the 13-fold higher estimate of
malaria deaths in India based on rural VA, versus hospital-
based malaria diagnoses [6].
Conclusions
PCVA and CCVA methods differ in their performance
of coding hospital-based deaths, and there is no single
best-performing method. Further testing of CCVAs is re-
quired to improve the performance of COD-assignment,
and the comparability between methods. In particular,
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there is a need for large, accessible datasets on which to
train and test automated methods in conjunction with
PCVA. More importantly, nationally representative VA
studies are required to improve the dearth of COD data
in most LMICs. These representative studies offer the
best hope to extend such testing from the hospital to the
community level, so as to compare various VA methods
where most deaths actually occur in LMICs - in rural
households without medical attention.
Additional files
: Description of PCVA and CCVA algorithmic and
probabilistic methods.
: Summary characteristics of reviewed comparison
studies.
: Chance-corrected concordance by cause for PCVA,
Tariff, RF and SSP.
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